Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Negrin

Showing results (21-30 of 163) with videos related to

Pageof 17
Sort By:
Methods (San Diego, Calif.)|September 6, 2003
Evaluation of effector cell fate and function by in vivo bioluminescence imagingMatthias Edinger, Petra Hoffmann, Christopher H Contag, et al.
Journal of Clinical Immunology|June 25, 2002
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and miceMichael R Verneris, Jeanette Baker, Matthias Edinger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2005
A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphomaThomas Leemhuis, Sandra Wells, Christian Scheffold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphomaWen-Kai Weng, Robert S Negrin, Philip Lavori, et al.
Journal of Cellular Biochemistry. Supplement|January 29, 2003
Understanding immune cell trafficking patterns via in vivo bioluminescence imagingStefanie Mandl, Christoph Schimmelpfennig, Matthias Edinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2009
Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantationJanelle A Olson, Robert Zeiser, Andreas Beilhack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
Plasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivoPia Björck, Andreas Beilhack, Edward I Herman, et al.
Frontiers in Transplantation|July 12, 2024
invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignanciesChaiyaporn Boonchalermvichian, Hao Yan, Biki Gupta, et al.
Cancer Research|October 18, 2002
Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3Christian Scheffold, Martin Kornacker, Yolanda C Scheffold, et al.
Blood|September 11, 2007
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activityRobert Zeiser, Sawsan Youssef, Jeanette Baker, et al.
Pageof 17

Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Methods (San Diego, Calif.)|September 6, 2003
Evaluation of effector cell fate and function by in vivo bioluminescence imagingMatthias Edinger, Petra Hoffmann, Christopher H Contag, et al.
Journal of Clinical Immunology|June 25, 2002
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and miceMichael R Verneris, Jeanette Baker, Matthias Edinger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2005
A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphomaThomas Leemhuis, Sandra Wells, Christian Scheffold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphomaWen-Kai Weng, Robert S Negrin, Philip Lavori, et al.
Journal of Cellular Biochemistry. Supplement|January 29, 2003
Understanding immune cell trafficking patterns via in vivo bioluminescence imagingStefanie Mandl, Christoph Schimmelpfennig, Matthias Edinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2009
Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantationJanelle A Olson, Robert Zeiser, Andreas Beilhack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
Plasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivoPia Björck, Andreas Beilhack, Edward I Herman, et al.
Frontiers in Transplantation|July 12, 2024
invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignanciesChaiyaporn Boonchalermvichian, Hao Yan, Biki Gupta, et al.
Cancer Research|October 18, 2002
Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3Christian Scheffold, Martin Kornacker, Yolanda C Scheffold, et al.
Blood|September 11, 2007
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activityRobert Zeiser, Sawsan Youssef, Jeanette Baker, et al.
Pageof 17